Alpha 2.0
Login Register
» Authors » Arcangelo Nocera

Arcangelo Nocera

Explore the profile of Arcangelo Nocera including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 108
Followers 0
Related Specialties
General Surgery
Nephrology
Allergy & Immunology
Top 10 Co-Authors
Fabrizio Ginevri
Patrizia Comoli
Massimo Cardillo
Michela Cioni
Iris Fontana
Augusto Tagliamacco
Sabrina Basso
Gian Marco Ghiggeri
Alberto Magnasco
Catherine Klersy
Published In
Transpl Int
Transpl Immunol
Clin Transplant
Blood
Contrib Nephrol
Affiliations
Soon will be listed here.
Recent Articles
1.
Control of BKPyV-DNAemia by a Tailored Viro-Immunologic Approach Does Not Lead to BKPyV-Nephropathy Progression and Development of Donor-Specific Antibodies in Pediatric Kidney Transplantation
Cioni M, Muscianisi S, De Cicco M, Basso S, Hirsch H, Fontana I, et al.
Microorganisms . 2025 Jan; 13(1). PMID: 39858816
Polyomavirus BK (BKPyV)-associated nephropathy (BKPyV-nephropathy) remains a significant cause of premature kidney allograft failure. In the absence of effective antiviral treatments, current therapeutic approaches rely on immunosuppression (IS) reduction, possibly...
2.
Anti-glutathione S-transferase theta 1 antibodies correlate with graft loss in non-sensitized pediatric kidney recipients
Comoli P, Cioni M, Ray B, Tagliamacco A, Innocente A, Caridi G, et al.
Front Med (Lausanne) . 2022 Dec; 9:1035400. PMID: 36530923
Introduction: Immunity to Human leukocyte antigen (HLA) cannot explain all cases of ABMR, nor the differences observed in the outcome of kidney recipients with circulating DSAs endowed with similar biologic...
3.
Post-transplant de novo non donor-specific HLA antibodies are not associated with poor graft outcome in non-sensitized pediatric recipients of kidney transplantation
Cioni M, Comoli P, Tagliamacco A, Innocente A, Basso S, Fontana I, et al.
Transpl Immunol . 2021 Feb; 65:101375. PMID: 33610675
While de novo donor-specific HLA antibodies (dnDSAs) have a detrimental impact on kidney graft outcome, the clinical significance of de novo non donor-specific antibodies (dnNDSAs) is more controversial. We retrospectively...
4.
Circulating B Cells With Memory and Antibody-Secreting Phenotypes Are Detectable in Pediatric Kidney Transplant Recipients Before the Development of Antibody-Mediated Rejection
Fischman C, Fribourg M, Fabrizio G, Cioni M, Comoli P, Nocera A, et al.
Transplant Direct . 2019 Oct; 5(9):e481. PMID: 31579809
Methods: We used time-of-flight mass cytometry to analyze prospectively collected peripheral blood mononuclear cells (PBMC) from pediatric kidney transplant recipients who developed DSA (DSA-positive recipients [DSA], n = 10). PBMC...
5.
Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study
Cioni M, Nocera A, Tagliamacco A, Basso S, Innocente A, Fontana I, et al.
Transpl Int . 2018 Aug; 32(1):38-48. PMID: 30076765
Current research is focusing on identifying bioclinical parameters for risk stratification of renal allograft loss, largely due to antibody-mediated rejection (AMR). We retrospectively investigated graft outcome predictors in 24 unsensitized...
6.
De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients
Cioni M, Nocera A, Innocente A, Tagliamacco A, Trivelli A, Basso S, et al.
J Immunol Res . 2017 Apr; 2017:1747030. PMID: 28367453
De novo posttransplant donor-specific HLA-antibody (DSA) detection is now recognized as a tool to identify patients at risk for antibody-mediated rejection (AMR) and graft loss. It is still unclear whether...
7.
Gene expression in highly sensitized dialysis patients waiting for a kidney transplant: A real-time PCR analysis
Tagliamacco A, Biticchi R, Garibotto G, Ginevri F, Nocera A
Transpl Immunol . 2015 Oct; 33(3):166-7. PMID: 26475986
No abstract available.
8.
Serum complement inactivation unveiled prepregnancy donor-specific HLA antibodies leading to postpartum kidney graft loss
Nocera A, Cioni M, Tagliamacco A, Comoli P, Innocente A, Ceriolo P, et al.
Transpl Int . 2015 Jan; 28(5):623-5. PMID: 25581245
No abstract available.
9.
Posttransplant soluble B-cell activating factor kinetics in pediatric recipients of first kidney allograft
Comoli P, Quartuccio G, Cioni M, Parodi A, Nocera A, Basso S, et al.
Transplantation . 2014 Jul; 99(1):243-9. PMID: 25033258
Background: Development of de novo donor-specific antibodies (dnDSA) is associated with late or chronic antibody-mediated rejection (CAMR) and poor graft outcome in low-risk kidney transplant recipients. High-level soluble B-cell activating...
10.
DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant
Tagliamacco A, Cioni M, Comoli P, Ramondetta M, Brambilla C, Trivelli A, et al.
Transpl Int . 2014 Mar; 27(7):667-73. PMID: 24629017
Data on the different HLA-antibody (Ab) categories in pediatric kidney recipients developing de novo donor-specific Abs (DSA) after transplantation are scarce. We retrospectively evaluated 82 consecutive nonsensitized pediatric recipients of...